Key result
Tele-monitoring significantly reduced systolic blood pressure (MD -4.927 mmHg; 95% CI -6.193 to -3.660; p<0.001) compared to usual care in patients with hypertension and diabetes.
Why the study?
Telemedicine has transformed healthcare delivery for chronic diseases, but the efficacy of telehealth-based interventions on disease control rates and clinical parameters in patients with hypertension and diabetes needed evaluation.
Does tele-monitoring improve blood pressure and glycemic control in patients with hypertension and type 2 diabetes mellitus compared to usual care?
Meta-Analysis (n=106,261)
Does tele-monitoring improve blood pressure and glycemic control in patients with hypertension and type 2 diabetes mellitus compared to usual care?
Mean Difference: -4.927 (95% CI -6.193–-3.66)
p-value: p=< 0.001
Telehealth interventions significantly improve blood pressure and glycemic control in patients with hypertension and type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Telehealth improves BP and glycemic control in hypertension and diabetes; confirms RCT efficacy and supports integration into routine care protocols.
Kelly et al. (2024) conducted a meta-analysis in hypertension and type 2 diabetes mellitus (n=106,261). tele-monitoring vs. usual care was evaluated on systolic blood pressure (SBP) (MD -4.927, 95% CI -6.193 to -3.660, p=< 0.001). Tele-monitoring significantly reduced systolic blood pressure (MD -4.927 mmHg; 95% CI -6.193 to -3.660; p<0.001) compared to usual care in patients with hypertension and diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: